Ovarian Cancer Early Detection Claims Are Biased

Visintin et al. ([1][1]) have reported a multiplex (six biomarker), bead-based immunoassay system as a candidate for ovarian cancer screening in high-risk populations. This assay has recently been marketed as an ovarian cancer screening test by LabCorp, under the trade name OvaSure ([2][2]), citing